Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile

Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile

Item
http://www.wikidata.org/entity/Q34540677
HIV drug resistance against strand transfer integrase inhibitorsOptimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens.Should we be testing for baseline integrase resistance in patients newly diagnosed with HIV?Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults.Human Immunodeficiency Virus Type 1 Drug Resistance Mutations Update.Antiviral Activity of Bictegravir and Cabotegravir Against Integrase Inhibitor Resistant SIVmac239 and HIV-1.Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes.Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and available of integrase inhibitors in Cape Town, South Africa.Investigational Antiretroviral Drugs: What is Coming Down the Pipeline.Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration.Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing.Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants.Anti-retroviral drugs: current state and development in the next decade.Structural Implications of Genotypic Variations in HIV-1 Integrase From Diverse SubtypesRecent advances in the discovery of small-molecule inhibitors of HIV-1 integraseSelective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravirProfile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date
P2860

Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile

Item
http://www.wikidata.org/entity/Q34540677
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Antiviral Activity of Bictegra ...... an Improved Resistance Profile
@ast
Antiviral Activity of Bictegra ...... an Improved Resistance Profile
@en
Antiviral Activity of Bictegra ...... an Improved Resistance Profile
@nl
type
label
Antiviral Activity of Bictegra ...... an Improved Resistance Profile
@ast
Antiviral Activity of Bictegra ...... an Improved Resistance Profile
@en
Antiviral Activity of Bictegra ...... an Improved Resistance Profile
@nl
prefLabel
Antiviral Activity of Bictegra ...... an Improved Resistance Profile
@ast
Antiviral Activity of Bictegra ...... an Improved Resistance Profile
@en
Antiviral Activity of Bictegra ...... an Improved Resistance Profile
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Antiviral Activity of Bictegra ...... an Improved Resistance Profile
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932